Mark Alan Goldberg's Net Worth

Mark Alan Goldberg's net worth is estimated to be at least $2,419,318.69 as of 07/21/2024. CoreStreet's estimation of Mark Alan Goldberg's net worth is based on their sale of stock and current holding of stock.

Mark Alan Goldberg is Director at Blueprint Medicines Corp. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,000 units of BPMC stock on 03/03/2022. Their biggest sale was on 12/24/2020 when they sold 5,455 units of Blueprint Medicines Corp stock for $681,875.00. They typically trade 1 times per year.

Total value of insider buys:
  • $592,103.69
Total value of insider sells:
  • $1,827,215.00
Most recent insider trade:
  • March 3, 2022

Mark Alan Goldberg's Insider Trading History

Blueprint Medicines CorpTitleAmountPriceTypeTotal Value
March 3, 2022
Director5,000$59.98Buy$299,900.00
Dec. 24, 2020
Director5,455$125.00Sell$681,875.00
Dec. 1, 2020
Director5,454$110.00Sell$599,940.00
Oct. 7, 2020
Director5,454$100.00Sell$545,400.00
ImmunoGen IncTitleAmountPriceTypeTotal Value
Nov. 6, 2018
Director30,000$5.76Buy$172,800.00
Dec. 15, 2016
Director20,000$1.80Buy$36,000.00
Nov. 8, 2012
Director3,000$11.27Buy$33,810.00
GlycoMimetics IncTitleAmountPriceTypeTotal Value
March 4, 2016
Director10,397$4.77Buy$49,593.69